| Model Number |
DIMENSION XPAND PLUS WITH HM |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/15/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
A discordant falsely elevated cardiac troponin-i (ltni) patient sample result was obtained on a dimension xpand plus with hm system.The discordant falsely elevated result was reported to the physician.The patient was sent to an alternate facility where a new sample was drawn and processed on an alternate siemens system.A lower result, considered correct, was obtained and reported.There are no known reports of adverse health consequences due to the discordant falsely elevated ltni patient result.
|
| |
|
Additional Manufacturer Narrative
|
|
A united states customer contacted the siemens healthcare diagnostics remote services center (rsc) regarding a discordant falsely elevated cardiac troponin-i (ltni) patient sample result obtained on a dimension xpand plus with hm system.Siemens is investigating the event.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: (20-may-2022).Siemens healthcare diagnostics inc.Has investigated the event of a discordant falsely elevated result with cardiac troponin i (ltni) on the dimension xpand plus system with lot ea2314.Siemens has confirmed that dimension cardiac troponin i (ltni) lot ea2314 shows a positive bias with lithium heparin plasma samples from individuals that are expected to be below the 99th percentile of 0.07 ng/ml [0.07 ug/l].Troponin values as high as 0.20 ng/ml [0.20 ug/l] have been observed with lithium heparin plasma that are expected to be within the 99th percentile.Serum samples collected from normal, healthy individuals whose results fall within the reference interval or below the 99th percentile of 0.07 ng/ml [0.07 ug/l] were not impacted by this issue.Urgent medical device correction, dc-22-02.A.Us dated may 18, 2022 and urgent field safety notice dc-22-0-02.A.Ous dated may-2022 was sent to all customers who had been shipped dimension cardiac troponin i (ltni) lot ea2314.Siemens recommended that customers use serum patient samples only when processing samples with ltni lot ea2314.The customer was instructed to discard ltni lot ea2314 if their laboratory is not able to use serum samples.Correction: sections d1, d2, d3, d4, g4 and h4 have been corrected to reflect the event have now been associated with dimension cardiac troponin i ltni assay lot ea2314 rather than a dimension xpand plus instrument issue.Section h6 codes have been updated per the hsc investigation.Initial mdr 2517506-2022-00122 was filed on 27-apr-2022.
|
| |
|
Search Alerts/Recalls
|